We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Integumen Plc | LSE:SKIN | London | Ordinary Share | GB00BMGWZY29 | ORD 0.1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 28.00 | 28.00 | 29.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
25/9/2020 22:33 | Thanks to shufflemman for GB's update-Skin will come good. Most of us are quids up here and bought for the technology. If you trade accept the risk but if you invest no concerns imo. | cumnor | |
25/9/2020 22:31 | Dear boris === The answer to your Covid-19 problem lies right under that nose of yours ==== Lucy learned to sniff out bladder, kidney and prostate cancer, and was even used in a study. Over the years, she has been able to detect cancer correctly more than 95% of the time. That's better than some lab tests used to diagnose cancer. Dogs' noses have 300 million sensors. Dogs have a second smelling device in the backs of their noses that we don't have, called the Jacobson's organ. This dog double smelling system allows trained dogs to detect cancer's unique odors, called volatile organic compounds. In 1989, doctors at King's College Hospital in London wrote in The Lancet about a woman whose dog persisted in smelling a particular mole on her leg. The mole turned out to be early-stage malignant melanoma. Over the next 26 years, studies from France to California to Italy have concluded that dogs really can detect the smell of cancer. Nov 8, 2018 - Dogs have an incredibly sensitive sense of smell that can detect the odor signatures of various types of cancer. Among others, they can detect colon cancer, prostate cancer, breast cancer, and melanoma by sniffing people's skin, bodily fluids, or breath. | buywell3 | |
25/9/2020 22:12 | From GB posted on the LSE BBTwo Years to Get Here - PerspectiveToday 22:02Evening All.As a large shareholder, I have seen the share price drop, and read the frustration in the comments. But a little perspective is needed. Look what has been achieved in the last 2 years. I am not just talking about the share price, which has been a reflection of the turnaround, but the application of technology that has existed for over 12 years in Labskin. 5 years work in Rinocloud and 30+ years in Modern Water monitoring division.We didn't set out to develop a COVID19 solution, we set out to transfer a successful project, developed over 4 years, supported by the Irish Environmental Protection Agency which was a 4 second E. Coli detection in water, and I install it into an base of Microtox equipment in 63 countries around the world.Even as lockdown came in March, we were fixated on and our expertise in bacteria production. It was May when we seen this as much a necessity as an opportunity.We made an offer to acquire MWG and disclosed it one month ago. It is expected to close early November.10+ partner, collaboration, cooperation, sub-contract consortium with Top 20 skincare, pharma, woundcare companies, footprint on 3 continents, and Microtox wastewater equipment being retrofitted with SARS-CoV-2 detection technology. That is going to market in Q1 2021,with interest across the globe. That is in the video if you watch it again.The virus can be detected on the same silicon chips for breath as it can in water. So Aptamers and Affimers have a high sensitivity that we use on the chip. If the virus is captured the alteration in the surface of the chip is detected from our experiments 100%.Now there are hurdles, but not many, and this will be launched in 2021, initially for SARS-CoV-2, but again in the video if the Affimers and Aptamers are raised for other pathogens, it will detect other pathogens (bacteria/viruses).B | the shuffle man | |
25/9/2020 20:55 | There is a possibility that a successful vaccine that provides up to 80% protection will not be found for years. Many scientists know this. | jungmana | |
25/9/2020 20:37 | Fair question... I thought of it. but I came to the conclusion all testing is currently being done on a voluntary basis like the current track n trace app which is currently provides little value in my opinion. No body even thinking about a foolproof option -so it is a step forward. What's the real benefit of faking it... apart from the malicious few. | shark fund | |
25/9/2020 20:29 | Quick question...why can't someone else use the breathalyser? If you wanted to go to a match but suspected you may have COVID then what is to stop you getting your one hundred per cent fit and healthy mate to breath into if for you? The only thing to stop that is having a steward watch you take the test which then means there will be queues. Just asking... | morrie1234 | |
25/9/2020 19:52 | Read back his posts then | quazie12 | |
25/9/2020 19:48 | Oh and one more thing..... these tests that Integumen are implementing aren't just designed around covid. They are for all sorts of 'nasties' that one may be unfortunate to contract. This was begun before covid ever became an issue. The average investor just doesn't seem to grasp this. | flashheart | |
25/9/2020 19:26 | No point.CEO says tests not ready for 4-5 months when a vaccine will be out in USA already.SKIN have missed the boat completely. | lithological heterogeneities | |
25/9/2020 19:10 | Interview on proactive inserted into the thread header but can be viewed here | mulligut | |
25/9/2020 19:03 | #SKIN #DVRG Window into potential revenue!!Conservativ | hamidahamida | |
25/9/2020 19:01 | Agree, a decent post but always better if it's what you want to hear isn't it. The CEO has lost a lot of credibility this week and one needs to ask who is he working for, investors or peeps who fund his scheme. | cocker | |
25/9/2020 18:59 | #SKIN #MWG bring it onhttps://www.cnbc.c | hamidahamida | |
25/9/2020 18:56 | Spending retirement making money on the markets sounds a sad, dead way to live when you could do anything. | yump | |
25/9/2020 18:52 | That's just the way he is. How about an RNS on Monday " Government agrees to fast track testing of innovative........" You know what I mean. | angus17 | |
25/9/2020 18:44 | Great - we have to play cluedo on his every word... | shark fund | |
25/9/2020 18:41 | Watch GB's video presentation he gave on proactive. The last sentence he made a very casual remark about being in touch with the presenter even though the presenter was going to be on holiday next week in Aussie. "look forward to speaking to you even down under....." Another special GB hint that we are in for more fun next week, hmmmmm I wonder. | angus17 | |
25/9/2020 18:38 | Excellent post montynj. Shines out amongst the usual drivel on here and sums up the company very nicely. | flashheart | |
25/9/2020 17:57 | What are the chances that mwg are even submitting a proposal? Still got a few hours to get it in... | shark fund | |
25/9/2020 17:52 | Totally agree...the Minion clip in his Twitter build up now looks embarrassing | morrie1234 | |
25/9/2020 17:41 | The problem is simple and if you are to naive or stupid to get it then you have serious problems. Tweeting the day before the rns #this and #that & insinuating a mind blowing announcement will come during the agm, was above and beyond what any CEO should be doing using social media to promote his PLC. Was this use of social media a pre planned plan to allow Helium to exit at a inflated price?. Well without doubt going into the weekend it has given many loyal followers food for thought. | cocker | |
25/9/2020 17:32 | Seems Biobot has a head start in the US...https://www.cnb | morrie1234 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions